198 related articles for article (PubMed ID: 17401529)
1. Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease.
Chen K; Kazachkov M; Yu PH
J Neural Transm (Vienna); 2007; 114(6):835-9. PubMed ID: 17401529
[TBL] [Abstract][Full Text] [Related]
2. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
Chen K; Maley J; Yu PH
J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
[TBL] [Abstract][Full Text] [Related]
3. Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats.
Deng Y; Boomsma F; Yu PH
Life Sci; 1998; 63(23):2049-58. PubMed ID: 9839528
[TBL] [Abstract][Full Text] [Related]
4. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination.
Kazachkov M; Chen K; Babiy S; Yu PH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1201-7. PubMed ID: 17596537
[TBL] [Abstract][Full Text] [Related]
5. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
Jiang ZJ; Richardson JS; Yu PH
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
7. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
8. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
9. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.
Schuessel K; Schäfer S; Bayer TA; Czech C; Pradier L; Müller-Spahn F; Müller WE; Eckert A
Neurobiol Dis; 2005 Feb; 18(1):89-99. PubMed ID: 15649699
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
11. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.
Siegel SJ; Bieschke J; Powers ET; Kelly JW
Biochemistry; 2007 Feb; 46(6):1503-10. PubMed ID: 17279615
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β metabolite sensing: biochemical linking of glycation modification and misfolding.
Fawver JN; Schall HE; Petrofes Chapa RD; Zhu X; Murray IV
J Alzheimers Dis; 2012; 30(1):63-73. PubMed ID: 22406446
[TBL] [Abstract][Full Text] [Related]
13. Aβ induces oxidative stress in senescence-accelerated (SAMP8) mice.
Takagane K; Nojima J; Mitsuhashi H; Suo S; Yanagihara D; Takaiwa F; Urano Y; Noguchi N; Ishiura S
Biosci Biotechnol Biochem; 2015; 79(6):912-8. PubMed ID: 25612552
[TBL] [Abstract][Full Text] [Related]
14. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
Barone E; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
[TBL] [Abstract][Full Text] [Related]
15. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
Deng Y; Yu PH
J Chromatogr Sci; 1999 Sep; 37(9):317-22. PubMed ID: 10497785
[TBL] [Abstract][Full Text] [Related]
17. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
Matsuoka Y; Picciano M; La Francois J; Duff K
Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
Yu PH
Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
[TBL] [Abstract][Full Text] [Related]
19. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
20. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
